Existing investors Prosus Ventures, Temasek Holdings, CDPQ and TPG are looking to invest up to INR 250 Cr into PharmEasy
PharmEasy is looking to raise up to $100 Mn (INR 824.64 Cr) in the current round, having raised INR 550 Cr through a rights issue in 2022
The development comes when PharmEasy needs to raise funding to meet a key covenant in the loan extended to it by Goldman Sachs
Online pharmacy unicorn PharmEasy has reportedly appointed Avendus Capital to raise equity funding. The move comes as its existing investors plan to infuse fresh capital to shore up the company.
Prosus Ventures, Temasek Holdings, CDPQ and TPG are looking to invest up to INR 250 Cr into PharmEasy, Mint reported citing sources. Avendus might also look for external investors for fundraising.